RA CAPITAL MANAGEMENT LLC 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | RA CAPITAL MANAGEMENT LLC | 0 0.000% | -2,850,000 (Position Closed) | Filing |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | RA CAPITAL MANAGEMENT LLC | 2,850,000 5.900% | 0 (Unchanged) | Filing |
| 2021-03-24 4:30 pm Purchase | 2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | RA CAPITAL MANAGEMENT LLC | 2,850,000 6.000% | 2,850,000 (New Position) | Filing |